These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

4162 related items for PubMed ID: 6409871

  • 1. Comparative antitumor activities of 7-N-(p-hydroxyphenyl)mitomycin C (M-83) and mitomycin C.
    Imai R, Morimoto M.
    J Antibiot (Tokyo); 1983 May; 36(5):559-65. PubMed ID: 6409871
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Azinomycins A and B, new antitumor antibiotics. III. Antitumor activity.
    Ishizeki S, Ohtsuka M, Irinoda K, Kukita K, Nagaoka K, Nakashima T.
    J Antibiot (Tokyo); 1987 Jan; 40(1):60-5. PubMed ID: 3104267
    [Abstract] [Full Text] [Related]

  • 4. Antitumor activity of a novel antitumor antibiotic, quinocarmycin citrate (KW2152).
    Fujimoto K, Oka T, Morimoto M.
    Cancer Res; 1987 Mar 15; 47(6):1516-22. PubMed ID: 2434218
    [Abstract] [Full Text] [Related]

  • 5. Gilvocarcins, new antitumor antibiotics. 3. Antitumor activity.
    Morimoto M, Okubo S, Tomita F, Marumo H.
    J Antibiot (Tokyo); 1981 Jun 15; 34(6):701-7. PubMed ID: 6792176
    [Abstract] [Full Text] [Related]

  • 6. Antitumor activity of 7-N-[[2-[[2-(gamma-L-glutamylamino)ethyl]dithio]ethyl]]-mitomycin C.
    Morimoto M, Ashizawa T, Ohno H, Azuma M, Kobayashi E, Okabe M, Gomi K, Kono M, Saitoh Y, Kanda Y.
    Cancer Res; 1991 Jan 01; 51(1):110-5. PubMed ID: 1988076
    [Abstract] [Full Text] [Related]

  • 7. Antitumor activity of mitomycin C-dextran conjugate against various murine tumors.
    Hashida M, Kato A, Kojima T, Muranishi S, Sezaki H, Tanigawa N, Satomura K, Hikasa Y.
    Gan; 1981 Apr 01; 72(2):226-34. PubMed ID: 6169584
    [Abstract] [Full Text] [Related]

  • 8. Characteristics of the antitumor activity of M-16 and M-18, major metabolites of a new mitomycin C derivative KW-2149, in mice.
    Ashizawa T, Okamoto A, Okabe M, Kobayashi S, Arai H, Saito H, Kasai M, Gomi K.
    Anticancer Drugs; 1995 Dec 01; 6(6):763-70. PubMed ID: 8845489
    [Abstract] [Full Text] [Related]

  • 9. The action of 7-N-(p-hydroxyphenyl)mitomycin C [M-83] in suppressing murine immune response.
    Okabe M, Imai R, Morimoto M.
    J Antibiot (Tokyo); 1982 Aug 01; 35(8):1055-62. PubMed ID: 6754673
    [Abstract] [Full Text] [Related]

  • 10. In vivo drug release and antitumor characteristics of water-soluble conjugates of mitomycin C with glycol-chitosan and N-succinyl-chitosan.
    Sato M, Onishi H, Takahara J, Machida Y, Nagai T.
    Biol Pharm Bull; 1996 Sep 01; 19(9):1170-7. PubMed ID: 8889036
    [Abstract] [Full Text] [Related]

  • 11. Antitumor activity and toxicity in animals of RR-150 (7-cysteaminomitosane), a new mitomycin derivative.
    Bradner WT, Rose WC, Schurig JE, Schlein A, Huftalen JB.
    Cancer Res; 1984 Dec 01; 44(12 Pt 1):5619-23. PubMed ID: 6437670
    [Abstract] [Full Text] [Related]

  • 12. Antitumor activity and toxicity in animals of N-7[2-(4-nitrophenyldithio) ethyl] mitomycin C (BMY-25067).
    Bradner WT, Rose WC, Schurig JE, Florczyk AP.
    Invest New Drugs; 1990 Dec 01; 8 Suppl 1():S1-7. PubMed ID: 2380013
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Mitomycin C combination therapy against murine tumor systems. Effectiveness with cyclophosphamide and methotrexate.
    Mabel JA, Wodinsky I.
    Cancer; 1983 Feb 15; 51(4):600-5. PubMed ID: 6401590
    [Abstract] [Full Text] [Related]

  • 15. Antitumor activity and toxicity in animals of BMY-25282, a new mitomycin derivative.
    Bradner WT, Rose WC, Schurig JE, Florczyk AP, Huftalen JB, Catino JJ.
    Cancer Res; 1985 Dec 15; 45(12 Pt 1):6475-81. PubMed ID: 3933826
    [Abstract] [Full Text] [Related]

  • 16. Antitumor activity and pharmacokinetics of 7-N-(p-hydroxyphenyl)mitomycin C in human tumor xenografts transplanted into nude mice.
    Asanuma F.
    J Antibiot (Tokyo); 1985 Mar 15; 38(3):401-10. PubMed ID: 4008332
    [Abstract] [Full Text] [Related]

  • 17. Antitumor activity of a derivative of mitomycin, 7-N-[2-[[2-(gamma-L-glutamylamino)ethyl]dithio]ethyl]mitomycin C (KW-2149), against murine and human tumors and a mitomycin C-resistant tumor in vitro and in vivo.
    Tsuruo T, Sudo Y, Asami N, Inaba M, Morimoto M.
    Cancer Chemother Pharmacol; 1990 Mar 15; 27(2):89-93. PubMed ID: 2123421
    [Abstract] [Full Text] [Related]

  • 18. In vivo properties of the conjugates of mitomycin C with estradiol benzoate and estradiol: pharmacokinetics and antitumor characteristics against P388 leukemia and sarcoma 180.
    Ishiki N, Onishi H, Machida Y.
    Biol Pharm Bull; 1998 Nov 15; 21(11):1180-6. PubMed ID: 9853409
    [Abstract] [Full Text] [Related]

  • 19. Enhancement of antitumor activity of mitomycin C in vitro and in vivo by UCN-01, a selective inhibitor of protein kinase C.
    Akinaga S, Nomura K, Gomi K, Okabe M.
    Cancer Chemother Pharmacol; 1993 Nov 15; 32(3):183-9. PubMed ID: 8500222
    [Abstract] [Full Text] [Related]

  • 20. [Potentiation of chemotherapeutic activity by a Chinese herb medicine juzen-taiho-toh].
    Komiyama K, Hirokawa Y, Zhibo Y, Umezawa I, Hata T.
    Gan To Kagaku Ryoho; 1988 May 15; 15(5):1715-9. PubMed ID: 3130806
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 209.